Senior insider sale
Chief Development Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$3.22M
111K shares
What this filing means
MYLES DAVID C. plans to sell 111K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $3.22M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/13/2026ACC: 0001959173-26-000286
Officer· Chief Development Officer
Since Nov 2020
111K
Shares to sell
$3.22M
Approx. market value
50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Option Granted 02/01/2023
Cash
1/13/2026
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2026 | Option Granted 02/01/2023 Cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$283.4K
1/12/2026
—Completed
Units to sell
51K
Market value
$1.55M
12/19/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$1.38M
1/13/2026
Total
Units
111K
Value
$3.22M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/12/2026 | 10K | $283.4K | — | Completed |
12/19/2025 | 51K | $1.55M | — | Completed |
| Planned — Approximate Date | ||||
1/13/2026 | 50K | $1.38M | NASDAQ | Planned |
| Total | 111K | $3.22M | ||